Effect of Proton Pump Inhibitor of Daily Use for One Month on Kidney Function Test

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-11-01

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study to:

evaluate the association between prolonged use of PPI and adverse renal outcomes on patients with normal renal function and others with abnormal renal function

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Daily Use Proton Pump Inhibitors for One Month on Kidney Function

NCT03910647

Proton Pump Inhibitor Allergy

UNKNOWN PHASE2

Is Long-Term Proton Pump Inhibitor Use a Cause of Leaky Gut Syndrome

NCT06268834

Proton Pump Inhibitor Adverse Reaction

COMPLETED NA

Proton Pump Inhibitor (PPI) Inappropriate Use and Economic Burden in Chinese Population

NCT03118778

Gastrointestinal Disease

COMPLETED

PPI Test in GP Patients

NCT00318084

GERD

COMPLETED PHASE4

Efficacy of Pantoprazole 20/40 mg Once Daily (od) in Patients Older Than 12 Years Who Have Gastrointestinal Symptoms of Reflux Disease

NCT00829738

Gastroesophageal Reflux Disease

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Proton pump inhibitors (PPIs) are one of the most widely used classes of drugs and are prescribed primarily for gastric acid-related diseases, eradication of Helicobacter pylori, and prevention of nonsteroidal anti-inflammatory drug (NSAID)-induced gastropathy,and gastroesophagial reflux diseases , Although PPIs have an excellent overall safety profile, some severe adverse effects, which include bone fracture, dementia, myocardial infarction, infections, micronutrient deficiencies, and kidney diseases, PPIs may trigger acute interstitial nephritis,a potentially sever adverse event commonly associated with acute kidney injury. The increase in prescription and inadequate use of this class of medication calls for studies on the effects of prolonged PPI therapy on renal function.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Proton Pump Inhibitor Allergy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

pantoprazole with normal kidney function

use pantoprazole for one month and after one month i will do for them kidney functions test

Group Type EXPERIMENTAL

Pantoprazole 40mg

Intervention Type DRUG

effect of this drug on renal function

pantoprazole with abnormal kidney function

use pantoprazole for one month and after one month i will do for them kidney functions test

Group Type EXPERIMENTAL

Pantoprazole 40mg

Intervention Type DRUG

effect of this drug on renal function

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pantoprazole 40mg

effect of this drug on renal function

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Protonix

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients with peptic ulcer disease or gastroesophagial reflux with normal l renal function
* patients with peptic ulcer disease or gastroeosophagial reflux with abnormal renal function

Exclusion Criteria

* 1- cigarette smoker: Cigarette smoking status was defined categorically as current,former, or never smoker at baseline.

2-biabetic patients: diabetes mellitus is defined by a fasting blood glucose concentration \>\_ 126 mg/dl ,random glucose level of \>200 mg 3-patients take corticosteroid 4-patients with hypersensitivity to these drugs

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes